We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants

Delisted

TCBPW was delisted on the 21st of March, 2025.

5 hedge funds and large institutions have $30.6K invested in TC BioPharm (Holdings) plc Warrants in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

17% less funds holding

Funds holding: 65 (-1)

72% less capital invested

Capital invested by funds: $108K → $30.6K (-$77.4K)

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$23.5K
AC
2
Armistice Capital
New York
$3.76K +1 +0%
ACM
3
Altium Capital Management
New York
$1.88K
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$1.41K +$1.79K +14,174 New
UBS Group
5
UBS Group
Switzerland
$20 +$25 +200 New
WAM
6
Warberg Asset Management
Illinois
-$10.9K -86,667 Closed
VF
7
Virtu Financial
New York
-$3K -21,182 Closed

TCBPW Hedge Fund Activity: Q1 2023 in Review

5 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q1 2023, worth a combined $30.6K — down 72% from $108K a quarter earlier.

Fund positioning in TCBPW was balanced in Q1 2023: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.79K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $10.9K sold.

  • 5 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q1 2023, down from 6 in Q4 2022.
  • Funds reported $30.6K of TC BioPharm (Holdings) plc Warrants stock for Q1 2023, down 72% quarter-over-quarter.
  • 2 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q1 2023 and 2 closed out, a net change of 0 holders.
  • The largest TC BioPharm (Holdings) plc Warrants buyer in Q1 2023 was Susquehanna International Group, an estimated $1.79K added.
  • The largest TC BioPharm (Holdings) plc Warrants seller in Q1 2023 was Warberg Asset Management, an estimated $10.9K sold.

Based on aggregated 13F filings for Q1 2023.